Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 3 |
| List of Tables | 4 | 1 |
| List of Figures | 4 | 1 |
| Introduction | 5 | 1 |
| Global Markets Direct Report Coverage | 5 | 1 |
| Schistosomiasis Overview | 6 | 1 |
| Therapeutics Development | 7 | 2 |
| Pipeline Products for Schistosomiasis Overview | 7 | 1 |
| Pipeline Products for Schistosomiasis Comparative Analysis | 8 | 1 |
| Schistosomiasis Therapeutics under Development by Companies | 9 | 1 |
| Schistosomiasis Therapeutics under Investigation by Universities/Institutes | 10 | 1 |
| Schistosomiasis Pipeline Products Glance | 11 | 2 |
| Clinical Stage Products | 11 | 1 |
| Early Stage Products | 12 | 1 |
| Schistosomiasis Products under Development by Companies | 13 | 1 |
| Schistosomiasis Products under Investigation by Universities/Institutes | 14 | 1 |
| Schistosomiasis Companies Involved in Therapeutics Development | 15 | 4 |
| Kancera AB | 15 | 1 |
| LondonPharma Ltd | 16 | 1 |
| Merck KGaA | 17 | 1 |
| Salvensis | 18 | 1 |
| Schistosomiasis Therapeutics Assessment | 19 | 5 |
| Assessment by Monotherapy Products | 19 | 1 |
| Assessment by Route of Administration | 20 | 2 |
| Assessment by Molecule Type | 22 | 2 |
| Drug Profiles | 24 | 10 |
| BDM-I Drug Profile | 24 | 2 |
| EDE-1102 Drug Profile | 26 | 1 |
| intestinal schistosomiasis vaccine Drug Profile | 27 | 1 |
| intestinal schistosomiasis vaccine Drug Profile | 28 | 1 |
| L-Praziquantel Drug Profile | 29 | 2 |
| Small Molecule for Schistosomiasis Drug Profile | 31 | 1 |
| Small Molecule for Schistosomiasis Drug Profile | 32 | 1 |
| Small Molecules for Schistosomiasis Drug Profile | 33 | 1 |
| Schistosomiasis Dormant Projects | 34 | 1 |
| Schistosomiasis Product Development Milestones | 35 | 3 |
| Featured News &Press Releases | 35 | 1 |
| Aug 23, 2013: BioDiem US patent for skin and wound infections | 35 | 1 |
| Feb 08, 2013: BioDiem Progresses To Proof-Of-Concept Testing Of BDM-I Antimicrobial Effect Against Parasites | 35 | 1 |
| Nov 08, 2012: BioDiem Partners With Griffith University To Enhance Antimicrobial Drug BDM-I | 35 | 1 |
| Oct 18, 2012: BioDiem Reports Continued Progress In Development Of Antimicrobial BDM-I | 36 | 1 |
| Aug 08, 2012: BioDiem Receives European Patent For Antimicrobial Compound BDM-I | 37 | 1 |
| Appendix | 38 | 2 |
| Methodology | 38 | 1 |
| Coverage | 38 | 1 |
| Secondary Research | 38 | 1 |
| Primary Research | 38 | 1 |
| Expert Panel Validation | 38 | 1 |
| Contact Us | 38 | 1 |
| Disclaimer | 39 | 1 |